West Pharmaceutical(WST) - 2023 Q4 - Earnings Call Presentation

Fourth-Quarter 2023 and Full Year Results WST Q4/FY 2023 Earnings 1 | --- | |-------------------------------------------------------------------------------| | Quarter Overall Net Sales $732.0M | 3.3% | | | | Diluted Earnings Per Share: $1.83 Adjusted Diluted Earnings Per Share: $1.83 | "We had strong 2023 base organic sales growth, excluding the headwinds from lower pandemic- related sales, led by high-value product (HVP) components and devices and contract manufacturing. Our continued investments in both ...